Back
United Therapeutics Stock Predictions
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55
UTHR
United Therapeutics
Last Price:
$305.93
Seasonality Move:
5.77%
7 Day Trial
ALL ACCESS PASS
$
7
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.United Therapeutics Stock Forecast
-
Over the next 52 weeks, United Therapeutics has on average historically risen by 18.9% based on the past 25 years of stock performance.
-
United Therapeutics has risen higher in 17 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 68%
-
Is United Therapeutics Stock Undervalued?The current United Therapeutics [UTHR] share price is $312.26. The Score for UTHR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
UTHR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will United Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, United Therapeutics has on average historically risen by 18.9% based on the past 25 years of stock performance.
United Therapeutics Stock Rating
Buy
55
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics overpriced?
-
United Therapeutics has risen higher in 17 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 68%
United Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
unither.com
52-Week Data
52-Week High:
417.82
52-Week Low:
227.75
Prediction Charts
Market Cap:
14B
Price in USD:
312.26
Volume:
461K
Beta:
0.53
Technical Analysis
SMA50:
337.65
SMA100:
354.05
SMA200:
346.13
52-Wk Change:
36.61%
Stock Predictions
-
Is United Therapeutics stock public?Yes, United Therapeutics is a publicly traded company.
-
What is the United Therapeutics stock quote today?The United Therapeutics stock price is 312.26 USD today.
-
How to buy United Therapeutics stock online?You can buy United Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-14 | 305.06 | 307.24 | 310.17 | 305.06 |
| Mar-17 | 307.86 | 322.94 | 324.22 | 304.55 |
| Mar-18 | 322.32 | 314.12 | 324.57 | 313.98 |
| Mar-19 | 315.17 | 318.85 | 319.07 | 307.64 |
| Mar-20 | 315.52 | 313.60 | 319.48 | 312.61 |
| Mar-21 | 311.18 | 312.99 | 315.69 | 308.43 |
| Mar-24 | 313.18 | 319.86 | 320.67 | 313.18 |
| Mar-25 | 322.32 | 316.73 | 322.32 | 312.38 |
| Mar-26 | 313.72 | 310.82 | 315.42 | 309.99 |
| Mar-27 | 311.87 | 308.02 | 318.40 | 307.57 |
| Mar-28 | 309.58 | 306.97 | 309.58 | 304.03 |
| Mar-31 | 303.77 | 308.27 | 309.64 | 298.60 |
| Apr-1 | 308.17 | 306.88 | 311.55 | 303.33 |
| Apr-2 | 303.78 | 312.26 | 313.41 | 303.16 |
United Therapeutics Earnings
United Therapeutics Earnings Report: Per Share United Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
United Therapeutics Forecast Revenue Growth
United Therapeutics Stock Analysis: Historical quarterly revenues per share for United Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.78 per share, a decrease next quarter of $0.81 per share, an increase this year of $2.65 per share, and an increase next year of $0.19 per share.
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.